Literature DB >> 7955614

Juvenile dermatomyositis: serial studies of circulating autoantibodies to a 56kD nuclear protein.

G Cambridge1, E Ovadia, D A Isenberg, V Dubowitz, J Sperling, R Sperling.   

Abstract

In this study we report that circulating antibodies recognising a 56kD protein, which is a component of large nuclear ribonuclear particles, are commonly found in children with juvenile onset dermatomyositis (JDM). These autoantibodies, as detected by Western blotting, were present in over 90% (24/26) of sera from JDM patients, which exceeds the number of patients with adult onset myositis who express this antibody (up to 85%). In addition, they were not found in healthy controls. Serial bleeds taken during the course of the disease in eleven children with JDM enabled us to follow the titre of anti-56kD autoantibodies. Sera were also tested by indirect immunofluorescence for anti-nuclear antibodies (ANA) using Hep2 cells as substrate. These studies revealed two distinct patient groups: Group 1 with anti-56kD antibody positive and ANA positive; and Group 2 with anti-56kD antibody positive and ANA negative. In Group 1 there was some correlation between disease activity and anti-56kD levels which was absent among patients in Group 2.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7955614

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  3 in total

Review 1.  Juvenile dermatomyositis: the association of the TNF alpha-308A allele and disease chronicity.

Authors:  L M Pachman; T O Fedczyna; T S Lechman; J Lutz
Journal:  Curr Rheumatol Rep       Date:  2001-10       Impact factor: 4.592

Review 2.  Idiopathic inflammatory myopathy: autoantibody update.

Authors:  Ira N Targoff
Journal:  Curr Rheumatol Rep       Date:  2002-10       Impact factor: 4.592

3.  Long-term oncologic safety of immediate reconstructive surgery in patients with invasive breast cancer: a retrospective matched-cohort study.

Authors:  Yanni Song; Shanshan Sun; Dalin Li; Jiguang Han; Ming Niu; Sai Luo; Haiqian Xu; Rui Huang; Sihang Zhang; Yang Wu; Qiqi Wu; Jing Xiong; Lijun Hao
Journal:  World J Surg Oncol       Date:  2021-12-20       Impact factor: 2.754

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.